Infection with COVID-19 in kidney transplant recipient with an elevated level of tacrolimus:one case report
An elevated risk of COVID-19 is due to long-term use of immunosuppressants in kidney transplant(KT)recipients.In this report,one patient received tacrolimus(TAC)for a long time to prevent rejection.And COVID-19 caused an abnormal blood drug concentration of TAC.Patho-logical factors and adverse heptorenal reactions leading to an elevated level of TAC were examined through a literature review.It provided references for analyzing pathological fac-tors in COVID-19 KT recipients and preventing adverse reac-tions of an abnormal blood concentration of TAC.